Dual mTORC1/2 Blockade Inhibits Glioblastoma Brain Tumor Initiating Cells in Vitro and in Vivo and Synergizes With Temozolomide to Increase Orthotopic Xenograft Survival

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-13-3389
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Zerumbone Causes Bax- And Bak-Mediated Apoptosis in Human Breast Cancer Cells and Inhibits Orthotopic Xenograft Growth in Vivo

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

CC-223 Blocks mTORC1/C2 Activation and Inhibits Human Hepatocellular Carcinoma Cells in Vitro and in Vivo

PLoS ONE
Multidisciplinary
2017English

A Dual Tracer 18f-FCH/18f-FDG PET Imaging of an Orthotopic Brain Tumor Xenograft Model

PLoS ONE
Multidisciplinary
2016English

Tumor-Initiating Cells in Malignant Brain Tumors

English

Quercetin Sensitizes Human Glioblastoma Cells to Temozolomide in Vitro via Inhibition of Hsp27

Acta Pharmacologica Sinica
MedicinePharmacology
2014English

CTLA-4 Blockade Synergizes With Cryoablation to Mediate Tumor Rejection

OncoImmunology
OncologyAllergyImmunology
2012English

Ethynyldeoxyuridine (EdU) Suppresses in Vitro Population Expansion and in Vivo Tumor Progression of Human Glioblastoma Cells

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2011English

Intracranial AAV-IFN-β Gene Therapy Eliminates Invasive Xenograft Glioblastoma and Improves Survival in Orthotopic Syngeneic Murine Model

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2017English

Continuous Local Delivery of Interferon-Β Stabilizes Tumor Vasculature in an Orthotopic Glioblastoma Xenograft Resection Model

Surgery
Surgery
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy